24 October 2018

Responding to a Canadian study revealing osteoporosis drug Denosumab could have a protective effect against breast cancer for post-menopausal women, Grete Brauten-Smith, Clinical Nurse Specialist at Breast Cancer Care, says:

“It’s fascinating to see Denosumab may have untapped potential and with more research could lower the risk of a breast cancer diagnosis for countless women. We already know that other similar bone strengthening drugs can reduce risk of breast cancer coming back.

“However, it’s important to remember this injection can have unpleasant side effects, including constipation and even jaw bone problems, and that the greatest risk factors for breast cancer - being a woman and getting older – remain out of our control. Anyone with questions can call Breast Cancer Care’s expert nurses on 0808 800 6000.”

-ENDS-

For further information, please contact:

Georgia Tilley, Press Officer, Breast Cancer Care

020 3105 3360 (out of hours 07702 901 334)

georgia.tilley@breastcancercare.org.uk

About Breast Cancer Care

Breast Cancer Care is the only specialist UK wide charity providing support for women, men, family and friends affected by breast cancer. We’ve been caring for them, supporting them, and campaigning on their behalf since 1973.

Today, we continue to offer a unique range of support including reliable information, one-to-one support over the phone and online from nurses and people who’ve been there. We also offer local group support across the UK.

From the moment someone notices something isn’t right, through to their treatment and beyond, we’re there to help people affected by breast cancer feel more in control. www.breastcancercare.org.uk